These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12893102)

  • 1. Treatment of depression in patients with heart disease.
    Roose SP
    Biol Psychiatry; 2003 Aug; 54(3):262-8. PubMed ID: 12893102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of depression in patients with heart disease.
    Roose SP; Miyazaki M
    Psychosom Med; 2005; 67 Suppl 1():S54-7. PubMed ID: 15953802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antidepressant drugs in patients with heart disease.
    Glassman AH; Rodriguez AI; Shapiro PA
    J Clin Psychiatry; 1998; 59 Suppl 10():16-21. PubMed ID: 9720478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of antidepressant drugs: updated.
    Glassman AH
    J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of depression in patients with heart disease.
    Roose SP; Spatz E
    J Clin Psychiatry; 1999; 60 Suppl 20():34-7. PubMed ID: 10513857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for the use of antidepressants in patients with cardiovascular disease.
    Roose SP
    Am Heart J; 2000 Oct; 140(4 Suppl):84-8. PubMed ID: 11011353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications.
    Marano G; Harnic D; Lotrionte M; Biondi-Zoccai G; Abbate A; Romagnoli E; Mazza M
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1123-47. PubMed ID: 19764865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in the medically ill: management considerations.
    Evans DL; Staab J; Ward H; Leserman J; Perkins DO; Golden RN; Petitto JM
    Depress Anxiety; 1996-1997; 4(4):199-208. PubMed ID: 9166652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.